About NextCure (NXTC)
NextCure, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on discovering and developing immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Through its Functional, Integrat... Read more
- USD0.48
- USD0.48
- USD0.47
- USD1.82
- 6.90%
- --
- 135.92k
- 14M
- 0.22
- -65.00%
Stock News
7 hours ago
Ternium: Latin Steelmaker Betting Big On Nearshoring - And It's Dirt Cheap
SeekingAlpha
7 hours ago
Why Skyrocketed Recursion Pharmaceuticals, Inc. (RXRX) Today
Yahoo
7 hours ago
ULTY: This Weekly Paying Option ETF Is For Risk Takers
SeekingAlpha
8 hours ago
Diamond Hill Small-Mid Cap Strategy Q1 2025 Commentary
SeekingAlpha
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
